Table 3.
Time, min | Met (2.5 mM) + ACSF | Met (2.5 mM) + 5-HT2A | Met (2.5 mM) + 5-HT7 | Met (2.5 mM)/cC + 5-HT7 |
---|---|---|---|---|
Baseline | 45.6 ± 7.0 | 41.5 ± 3.0 | 44.0 ± 2.0 | 45.8 ± 1.3 |
30 | 45.4 ± 6.6 | 42.1 ± 2.2 | 44.5 ± 2.2 | 45.9 ± 1.5 |
60 | 45.2 ± 6.7 | 41.4 ± 1.6 | 44.1 ± 2.5 | 46.8 ± 1.5 |
90 | 45.6 ± 6.4 | 41.1 ± 3.8 | 43.7 ± 1.8 | 46.0 ± 1.4 |
Baseline | 300 ± 54 | 300 ± 23 | 310 ± 26 | 310 ± 25 |
30 | 298 ± 37 | 297 ± 19 | 315 ± 12 | 301 ± 21 |
60 | 292 ± 34 | 288 ± 21 | 304 ± 17 | 293 ± 18 |
90 | 295 ± 34 | 284 ± 24 | 302 ± 13 | 282 ± 20 |
MAP, mmHg | ||||
Baseline | 129 ± 21 | 122 ± 10 | 129 ± 25 | 131 ± 16 |
30 | 128 ± 19 | 132 ± 12 | 123 ± 25 | 126 ± 14 |
60 | 128 ± 23 | 137 ± 14 | 119 ± 20 | 123 ± 17 |
90 | 131 ± 21 | 134 ± 13 | 114 ± 15 | 119 ± 12 |
pH | ||||
Baseline | 7.36 ± 0.05 | 7.40 ± 0.02 | 7.38 ± 0.02 | 7.37 ± 0.03 |
30 | 7.37 ± 0.04 | 7.41 ± 0.05 | 7.39 ± 0.03 | 7.37 ± 0.03 |
60 | 7.38 ± 0.05 | 7.42 ± 0.06 | 7.38 ± 0.02 | 7.37 ± 0.02 |
90 | 7.37 ± 0.04 | 7.41 ± 0.07 | 7.39 ± 0.01 | 7.36 ± 0.02 |
sBE | ||||
Baseline | 0.2 ± 1.6 | 0.6 ± 1.6 | 0.8 ± 1.5 | 1.2 ± 2.0 |
30 | 1.1 ± 1.8 | 2.6 ± 5.2 | 2.1 ± 1.4 | 0.9 ± 1.9 |
60 | 1.0 ± 1.4 | 2.5 ± 4.0 | 1.3 ± 1.1 | 1.8 ± 1.3 |
90 | 1.0 ± 0.9 | 1.0 ± 3.3 | 1.3 ± 0.9 | 0.6 ± 1.3 |
Temperature, °C | ||||
Baseline | 37.4 ± 0.7 | 37.7 ± 0.8 | 37.4 ± 0.5 | 37.7 ± 0.4 |
30 | 37.8 ± 0.4 | 37.3 ± 0.5 | 37.4 ± 0.5 | 37.6 ± 0.4 |
60 | 38.1 ± 0.6 | 37.3 ± 0.4 | 37.7 ± 0.1 | 37.6 ± 0.5 |
90 | 38.0 ± 0.6 | 37.5 ± 0.7 | 37.4 ± 0.3 | 37.6 ± 0.5 |
Met, metformin; cC, compound C; ACSF, artificial cerebrospinal fluid; 5-HT2A, serotonin type 2A receptor; 5-HT7, serotonin 7 receptor; MAP, mean arterial pressure; sBE, standard base excess.